Outlook Therapeutics Inc (OTLK)
7.58
-0.15
(-1.94%)
USD |
NASDAQ |
May 10, 16:00
7.58
0.00 (0.00%)
After-Hours: 20:00
Outlook Therapeutics Price: 7.58 for May 10, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 09, 2024 | 8.18 | 8.18 | 7.602 | 7.73 | 211451.0 |
May 08, 2024 | 8.20 | 8.26 | 7.81 | 8.00 | 455100.0 |
May 07, 2024 | 8.61 | 8.76 | 8.17 | 8.21 | 200305.0 |
May 06, 2024 | 8.91 | 8.91 | 8.450 | 8.50 | 241264.0 |
May 03, 2024 | 8.57 | 8.88 | 8.515 | 8.60 | 101290.0 |
May 02, 2024 | 8.60 | 8.605 | 8.270 | 8.50 | 202853.0 |
May 01, 2024 | 8.93 | 9.123 | 8.49 | 8.50 | 194073.0 |
Apr 30, 2024 | 9.10 | 9.290 | 8.811 | 8.92 | 207808.0 |
Apr 29, 2024 | 8.35 | 9.19 | 8.35 | 9.10 | 177405.0 |
Apr 26, 2024 | 8.22 | 8.50 | 8.135 | 8.43 | 120913.0 |
Apr 25, 2024 | 8.14 | 8.37 | 7.85 | 8.19 | 150771.0 |
Apr 24, 2024 | 8.29 | 8.66 | 8.00 | 8.20 | 339980.0 |
Apr 23, 2024 | 8.21 | 8.44 | 8.15 | 8.20 | 151657.0 |
Apr 22, 2024 | 8.27 | 8.365 | 7.80 | 8.09 | 210765.0 |
Apr 19, 2024 | 8.28 | 8.63 | 8.00 | 8.17 | 271784.0 |
Apr 18, 2024 | 8.79 | 8.835 | 8.121 | 8.29 | 234621.0 |
Apr 17, 2024 | 8.93 | 9.26 | 8.53 | 8.61 | 418152.0 |
Apr 16, 2024 | 8.54 | 9.040 | 8.54 | 8.75 | 136801.0 |
Apr 15, 2024 | 8.50 | 8.79 | 8.44 | 8.62 | 234921.0 |
Apr 12, 2024 | 9.03 | 9.19 | 8.610 | 8.70 | 267111.0 |
Apr 11, 2024 | 9.09 | 9.34 | 8.75 | 9.04 | 394021.0 |
Apr 10, 2024 | 9.06 | 9.15 | 8.55 | 8.99 | 503035.0 |
Apr 09, 2024 | 9.35 | 9.98 | 9.03 | 9.26 | 359778.0 |
Apr 08, 2024 | 9.23 | 9.48 | 8.89 | 9.35 | 248028.0 |
Apr 05, 2024 | 9.50 | 9.61 | 9.050 | 9.26 | 198467.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
4.072
Minimum
Sep 08 2023
66.20
Maximum
Feb 08 2021
26.43
Average
24.40
Median
Oct 23 2019
Price Benchmarks
Cutera Inc | 2.18 |
Actinium Pharmaceuticals Inc | 8.73 |
GT Biopharma Inc | 3.30 |
Karyopharm Therapeutics Inc | 1.09 |
Marinus Pharmaceuticals Inc | 1.34 |
Price Related Metrics
PS Ratio | 12.03 |
Earnings Yield | -52.77% |
Market Cap | 163.61M |